Robert Barrow

Chief Executive Officer and Board Director

Mr. Barrow is an accomplished pharmaceutical executive and clinical pharmacologist with over a decade of experience leading drug development programs in a variety of disease areas. After joining MindMed as Chief Development Officer in January 2021, he was named CEO in June 2021.

Mr. Barrow previously served as Director of Drug Development & Discovery at Usona Institute, where he oversaw preclinical, clinical and regulatory development efforts for all of Usona’s development programs. Prior to joining Usona, Mr. Barrow served as Chief Operating Officer of Olatec Therapeutics where he oversaw the execution of numerous early- and late-stage clinical trials in the fields of analgesics, rheumatology, immunology and cardiovascular disease. In addition, he has been responsible for the design and execution of preclinical research programs for new molecular entity drugs in CNS conditions such as multiple sclerosis, Alzheimer’s Disease and Parkinson’s Disease.

Mr. Barrow holds a Masters degree in Pharmacology from The Ohio State University and a Bachelor of Science degree from Wake Forest University, where he graduated summa cum laude.

Robert Barrow Portrait

Robert Barrow

Chief Executive Officer and Board Director

Carol Vallone Portrait

Carol Vallone

Chair of the Board of Directors, Chair of Compensation Committee, Member of Audit/Finance Committee

Andreas Krebs Portrait

Andreas Krebs

Vice Chair of the Board of Directors, Chair of Nomination and Governance Committee, Member of Audit/Finance Committee

Brigid Makes Portrait

Brigid Makes

Board Director, Chair of Audit Committee

Roger Crystal, MD Portrait

Roger Crystal, MD

Board Director, Member of Nomination & Governance Committee, Member of Compensation Committee

Suzanne Bruhn, PhD Portrait

Suzanne Bruhn, PhD

Board Director, Member of Nomination & Governance Committee, Member of Compensation Committee

Miri Halperin Wernli, PhD Portrait

Miri Halperin Wernli, PhD

Executive President

Daniel Karlin, MD, MA Portrait

Daniel Karlin, MD, MA

Chief Medical Officer

Schond Greenway, MBA Portrait

Schond Greenway, MBA

Chief Financial Officer

Francois Lilienthal, MD, MBA Portrait

Francois Lilienthal, MD, MBA

Chief Commercial Officer

Carrie Liao, CPA Portrait

Carrie Liao, CPA

Chief Accounting Officer

Robert Silva, PhD Portrait

Robert Silva, PhD

VP, Head of Development

Robert Malenka, MD, PhD Portrait

Robert Malenka, MD, PhD

Chairman of the Scientific Advisory Board, Nancy Friend Pritzker Professor in Psychiatry and Behavioral Sciences at Stanford University

Peter Bergethon, MD Portrait

Peter Bergethon, MD

Member, Scientific Advisory Board VP, Head of Quantitative & Clinical Technologies, Biogen, Inc.

Robert Dworkin, PhD Portrait

Robert Dworkin, PhD

Professor of Anesthesiology and Perioperative Medicine, Neurology, and Psychiatry at University of Rochester

Maurizio Fava, MD Portrait

Maurizio Fava, MD

Psychiatrist-in-Chief of the Massachusetts General Hospital (MGH)

Bridget Walton, MS Portrait

Bridget Walton, MS

VP, Global Regulatory Affairs

Peter Mack, PhD Portrait

Peter Mack, PhD

VP, Pharmaceutical Development

Carole Abel, MBA Portrait

Carole Abel, MBA

VP, Programs and Portfolio Office (PPO)

Maxim Jacobs, CFA

VP, Investor Relations and Corporate Communications

Maria Oquendo, MD, PhD Portrait

Maria Oquendo, MD, PhD

Ruth Meltzer Professor and Chairman of Psychiatry at University of Pennsylvania, Psychiatrist-in-Chief at the Hospital of the University of Pennsylvania

Matthias Liechti, MD, PhD Portrait

Matthias Liechti, MD, PhD

Scientific Collaborator & Advisor

Kim PC Kuypers, PhD Portrait

Kim PC Kuypers, PhD

Scientific Collaborator & Advisor

Peter Gasser, MD Portrait

Peter Gasser, MD

Clinical Advisor